99 related articles for article (PubMed ID: 29661763)
1. Outcomes of Contemporary Family Screening in Hypertrophic Cardiomyopathy.
van Velzen HG; Schinkel AFL; Baart SJ; Oldenburg RA; Frohn-Mulder IME; van Slegtenhorst MA; Michels M
Circ Genom Precis Med; 2018 Apr; 11(4):e001896. PubMed ID: 29661763
[TBL] [Abstract][Full Text] [Related]
2. Relationship Between Genotype Status and Clinical Outcome in Hypertrophic Cardiomyopathy.
Bonaventura J; Rowin EJ; Chan RH; Chin MT; Puchnerova V; Polakova E; Macek M; Votypka P; Batorsky R; Perera G; Koethe B; Veselka J; Maron BJ; Maron MS
J Am Heart Assoc; 2024 May; 13(10):e033565. PubMed ID: 38757491
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic spectrum of the first Belgian
Boen HM; Alaerts M; Van Laer L; Saenen JB; Goovaerts I; Bastianen J; Koopman P; Vanduynhoven P; De Vuyst E; Rosseel M; Heidbuchel H; Van Craenenbroeck EM; Loeys B
Front Genet; 2024; 15():1392527. PubMed ID: 38836037
[TBL] [Abstract][Full Text] [Related]
4. Survival analysis and gender differences in hypertrophic cardiomyopathy proband patients referred for genetic testing.
Lorca R; Salgado M; Álvarez-Velasco R; Reguro JR; Alonso V; Gómez J; Coto E; Cuesta-Llavona E; Lopez-Negrete E; Pascual I; Avanzas P; Tome M
Int J Cardiol; 2024 Aug; 408():132117. PubMed ID: 38710232
[TBL] [Abstract][Full Text] [Related]
5. Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing?
Mazzarotto F; Olivotto I; Boschi B; Girolami F; Poggesi C; Barton PJR; Walsh R
J Am Heart Assoc; 2020 Apr; 9(8):e015473. PubMed ID: 32306808
[TBL] [Abstract][Full Text] [Related]
6. Major Cardiac Events in Patients and Relatives With Hereditary Hypertrophic Cardiomyopathy.
Nielsen SK; Hansen FG; Rasmussen TB; Fischer T; Lassen JF; Madsen T; Møller DS; Klausen IC; Jensen MSK; Mogensen J
JACC Adv; 2023 Oct; 2(8):100604. PubMed ID: 38938358
[TBL] [Abstract][Full Text] [Related]
7. Hypertrophic cardiomyopathy and ultra-endurance running - two incompatible entities?
Wilson MG; Chandra N; Papadakis M; O'Hanlon R; Prasad SK; Sharma S
J Cardiovasc Magn Reson; 2011 Nov; 13(1):77. PubMed ID: 22122802
[TBL] [Abstract][Full Text] [Related]
8. Evaluating a communication aid for return of genetic results in families with hypertrophic cardiomyopathy: A randomized controlled trial.
Burns C; Yeates L; Sweeting J; Semsarian C; Ingles J
J Genet Couns; 2023 Apr; 32(2):425-434. PubMed ID: 36385718
[TBL] [Abstract][Full Text] [Related]
9. Benefits, harms, and costs of newborn genetic screening for hypertrophic cardiomyopathy: Estimates from the PreEMPT model.
Christensen KD; McMahon PM; Galbraith LN; Yeh JM; Stout NK; Lu CY; Stein S; Zhao M; Hylind RJ; Wu AC
Genet Med; 2023 Apr; 25(4):100797. PubMed ID: 36727595
[TBL] [Abstract][Full Text] [Related]
10. Implementing a clinical scientist-led screening clinic for hypertrophic and dilated cardiomyopathies.
Draper J; Bastiaenen R; Carr-White G; Bueser T; Webb J; Evans C; Nuthoo S; Sheikh N
Echo Res Pract; 2024 Apr; 11(1):10. PubMed ID: 38627858
[TBL] [Abstract][Full Text] [Related]
11. Cascade testing after exome sequencing: Retrospective analysis of linked family data at 2 US laboratories.
Stefka J; Streff H; Liu P; Towne M; Smith HS
Genet Med; 2023 May; 25(5):100818. PubMed ID: 36852743
[TBL] [Abstract][Full Text] [Related]
12. Human Genetics of Cardiomyopathies.
Houweling AC; Lekanne Deprez RH; Wilde AAM
Adv Exp Med Biol; 2024; 1441():977-990. PubMed ID: 38884765
[TBL] [Abstract][Full Text] [Related]
13. Liminality between direct and family-mediated contact in the communication of genetic information to at-risk relatives.
Mendes Á; Newson AJ
Eur J Hum Genet; 2024 May; 32(5):477-478. PubMed ID: 38627543
[No Abstract] [Full Text] [Related]
14. Actionability and familial uptake following opportunistic genomic screening in a pediatric cancer cohort.
Hammer-Hansen S; Stoltze U; Bartels E; Hansen TVO; Byrjalsen A; Tybjærg-Hansen A; Juul K; Schmiegelow K; Tfelt J; Bundgaard H; Wadt K; Diness BR
Eur J Hum Genet; 2024 May; ():. PubMed ID: 38740897
[TBL] [Abstract][Full Text] [Related]
15. Genotype Analysis as a Clinical Tool for Families in Hypertrophic Cardiomyopathy.
Sherrid MV; Massera D
JACC Adv; 2023 Oct; 2(8):100605. PubMed ID: 38938351
[No Abstract] [Full Text] [Related]
16. Follow-up and prognosis of HCM.
Dominguez F; Sanz-Sánchez J; García-Pavía P; Zorio E
Glob Cardiol Sci Pract; 2018 Aug; 2018(3):33. PubMed ID: 30393645
[No Abstract] [Full Text] [Related]
17. Family Matters: Outcomes of Hypertrophic Cardiomyopathy Family Screening.
Ingles J; Semsarian C
Circ Genom Precis Med; 2018 Apr; 11(4):e002112. PubMed ID: 29661764
[No Abstract] [Full Text] [Related]
18. Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significance.
van Lint FHM; Mook ORF; Alders M; Bikker H; Lekanne Dit Deprez RH; Christiaans I
Neth Heart J; 2019 Jun; 27(6):304-309. PubMed ID: 30847666
[TBL] [Abstract][Full Text] [Related]
19. Harmonizing Clinical Sequencing and Interpretation for the eMERGE III Network.
;
Am J Hum Genet; 2019 Sep; 105(3):588-605. PubMed ID: 31447099
[TBL] [Abstract][Full Text] [Related]
20. Management of hypertrophic cardiomyopathy.
Zhang Y; Adamo M; Zou C; Porcari A; Tomasoni D; Rossi M; Merlo M; Liu H; Wang J; Zhou P; Metra M; Sinagra G; Zhang J
J Cardiovasc Med (Hagerstown); 2024 Jun; 25(6):399-419. PubMed ID: 38625835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
